Document Preview Unavailable

Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo‐controlled, double‐blind, multicenter trial

Chieh‐Hsiang Lu; Kyung Wan Min; Lee‐Ming Chuang; Kokubo, Satoshi; Yoshida, Satoshi; et al.  Journal of Diabetes Investigation Vol. 7, Iss. 3,  (May 2016): 366-373.

You might have access to this document